AKT1 and neoplasm: The fact that RER treatment reduced the levels of the phosphorylated AKT and mTOR in tumor cells in our study and that TGF-β was shown to rapidly activate AKT by others [42–45] suggest that RER might have also neutralized TGF-β signaling in the prostate epithelial cells.